 | • レポートコード：D0804-16815 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腫瘍塞栓術の世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍塞栓術の種類別市場規模（経動脈塞栓術（TAE）、薬剤溶出ビーズ化学塞栓術（DEB-TACE）、放射線塞栓術（RE）、その他）、用途別市場規模（病院、外来手術センター、専門クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Boston Scientific Corporation、Sirtex Medical、Varian Medical Systems, Inc.、Nordion (Sotera Health) ・地域別グローバル市場分析 2015年-2020年 ・腫瘍塞栓術の北米市場（アメリカ、カナダ、メキシコ） ・腫瘍塞栓術のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腫瘍塞栓術のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腫瘍塞栓術の南米市場（ブラジル、アルゼンチン） ・腫瘍塞栓術の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経動脈塞栓術（TAE）、薬剤溶出ビーズ化学塞栓術（DEB-TACE）、放射線塞栓術（RE）、その他 ・用途別分析：病院、外来手術センター、専門クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Tumor Embolization market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tumor Embolization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tumor Embolization market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tumor Embolization market has been segmented into:
Trans-Arterial Embolization (TAE)
Drug-Eluting Bead Chemoembolization (DEB-TACE)
Radioembolization (RE)
Others
By Application, Tumor Embolization has been segmented into:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tumor Embolization market presented in the report. This section sheds light on the sales growth of different regional and country-level Tumor Embolization markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tumor Embolization market.
The report offers in-depth assessment of the growth and other aspects of the Tumor Embolization market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tumor Embolization Market Share Analysis
Tumor Embolization competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tumor Embolization sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tumor Embolization sales, revenue and market share for each player covered in this report.
The major players covered in Tumor Embolization are:
Boston Scientific Corporation
Sirtex Medical
Varian Medical Systems, Inc.
Nordion (Sotera Health)
Table of Contents
1 Tumor Embolization Market Overview
1.1 Product Overview and Scope of Tumor Embolization
1.2 Classification of Tumor Embolization by Type
1.2.1 Global Tumor Embolization Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tumor Embolization Revenue Market Share by Type in 2019
1.2.3 Trans-Arterial Embolization (TAE)
1.2.4 Drug-Eluting Bead Chemoembolization (DEB-TACE)
1.2.5 Radioembolization (RE)
1.2.6 Others
1.3 Global Tumor Embolization Market by Application
1.3.1 Overview: Global Tumor Embolization Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Tumor Embolization Market by Regions
1.4.1 Global Tumor Embolization Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tumor Embolization (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tumor Embolization Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tumor Embolization Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tumor Embolization Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tumor Embolization Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tumor Embolization Status and Prospect (2015-2025)
2 Company Profiles
2.1 Boston Scientific Corporation
2.1.1 Boston Scientific Corporation Details
2.1.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boston Scientific Corporation SWOT Analysis
2.1.4 Boston Scientific Corporation Product and Services
2.1.5 Boston Scientific Corporation Tumor Embolization Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sirtex Medical
2.2.1 Sirtex Medical Details
2.2.2 Sirtex Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sirtex Medical SWOT Analysis
2.2.4 Sirtex Medical Product and Services
2.2.5 Sirtex Medical Tumor Embolization Revenue, Gross Margin and Market Share (2018-2019)
2.3 Varian Medical Systems, Inc.
2.3.1 Varian Medical Systems, Inc. Details
2.3.2 Varian Medical Systems, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Varian Medical Systems, Inc. SWOT Analysis
2.3.4 Varian Medical Systems, Inc. Product and Services
2.3.5 Varian Medical Systems, Inc. Tumor Embolization Revenue, Gross Margin and Market Share (2018-2019)
2.4 Nordion (Sotera Health)
2.4.1 Nordion (Sotera Health) Details
2.4.2 Nordion (Sotera Health) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Nordion (Sotera Health) SWOT Analysis
2.4.4 Nordion (Sotera Health) Product and Services
2.4.5 Nordion (Sotera Health) Tumor Embolization Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tumor Embolization Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tumor Embolization Players Market Share
3.2.2 Top 10 Tumor Embolization Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tumor Embolization Revenue and Market Share by Regions
4.2 North America Tumor Embolization Revenue and Growth Rate (2015-2020)
4.3 Europe Tumor Embolization Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tumor Embolization Revenue and Growth Rate (2015-2020)
4.5 South America Tumor Embolization Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tumor Embolization Revenue and Growth Rate (2015-2020)
5 North America Tumor Embolization Revenue by Countries
5.1 North America Tumor Embolization Revenue by Countries (2015-2020)
5.2 USA Tumor Embolization Revenue and Growth Rate (2015-2020)
5.3 Canada Tumor Embolization Revenue and Growth Rate (2015-2020)
5.4 Mexico Tumor Embolization Revenue and Growth Rate (2015-2020)
6 Europe Tumor Embolization Revenue by Countries
6.1 Europe Tumor Embolization Revenue by Countries (2015-2020)
6.2 Germany Tumor Embolization Revenue and Growth Rate (2015-2020)
6.3 UK Tumor Embolization Revenue and Growth Rate (2015-2020)
6.4 France Tumor Embolization Revenue and Growth Rate (2015-2020)
6.5 Russia Tumor Embolization Revenue and Growth Rate (2015-2020)
6.6 Italy Tumor Embolization Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tumor Embolization Revenue by Countries
7.1 Asia-Pacific Tumor Embolization Revenue by Countries (2015-2020)
7.2 China Tumor Embolization Revenue and Growth Rate (2015-2020)
7.3 Japan Tumor Embolization Revenue and Growth Rate (2015-2020)
7.4 Korea Tumor Embolization Revenue and Growth Rate (2015-2020)
7.5 India Tumor Embolization Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tumor Embolization Revenue and Growth Rate (2015-2020)
8 South America Tumor Embolization Revenue by Countries
8.1 South America Tumor Embolization Revenue by Countries (2015-2020)
8.2 Brazil Tumor Embolization Revenue and Growth Rate (2015-2020)
8.3 Argentina Tumor Embolization Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tumor Embolization by Countries
9.1 Middle East & Africa Tumor Embolization Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tumor Embolization Revenue and Growth Rate (2015-2020)
9.3 UAE Tumor Embolization Revenue and Growth Rate (2015-2020)
9.4 Egypt Tumor Embolization Revenue and Growth Rate (2015-2020)
9.5 South Africa Tumor Embolization Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tumor Embolization Revenue and Market Share by Type (2015-2020)
10.2 Global Tumor Embolization Market Forecast by Type (2019-2024)
10.3 Trans-Arterial Embolization (TAE) Revenue Growth Rate (2015-2025)
10.4 Drug-Eluting Bead Chemoembolization (DEB-TACE) Revenue Growth Rate (2015-2025)
10.5 Radioembolization (RE) Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Tumor Embolization Market Segment by Application
11.1 Global Tumor Embolization Revenue Market Share by Application (2015-2020)
11.2 Tumor Embolization Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Specialty Clinics Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Tumor Embolization Market Size Forecast (2021-2025)
12.1 Global Tumor Embolization Market Size Forecast (2021-2025)
12.2 Global Tumor Embolization Market Forecast by Regions (2021-2025)
12.3 North America Tumor Embolization Revenue Market Forecast (2021-2025)
12.4 Europe Tumor Embolization Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tumor Embolization Revenue Market Forecast (2021-2025)
12.6 South America Tumor Embolization Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tumor Embolization Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tumor Embolization Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tumor Embolization by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tumor Embolization Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tumor Embolization Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Boston Scientific Corporation Corporate Information, Location and Competitors
Table 6. Boston Scientific Corporation Tumor Embolization Major Business
Table 7. Boston Scientific Corporation Tumor Embolization Total Revenue (USD Million) (2017-2018)
Table 8. Boston Scientific Corporation SWOT Analysis
Table 9. Boston Scientific Corporation Tumor Embolization Product and Solutions
Table 10. Boston Scientific Corporation Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sirtex Medical Corporate Information, Location and Competitors
Table 12. Sirtex Medical Tumor Embolization Major Business
Table 13. Sirtex Medical Tumor Embolization Total Revenue (USD Million) (2018-2019)
Table 14. Sirtex Medical SWOT Analysis
Table 15. Sirtex Medical Tumor Embolization Product and Solutions
Table 16. Sirtex Medical Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Varian Medical Systems, Inc. Corporate Information, Location and Competitors
Table 18. Varian Medical Systems, Inc. Tumor Embolization Major Business
Table 19. Varian Medical Systems, Inc. Tumor Embolization Total Revenue (USD Million) (2017-2018)
Table 20. Varian Medical Systems, Inc. SWOT Analysis
Table 21. Varian Medical Systems, Inc. Tumor Embolization Product and Solutions
Table 22. Varian Medical Systems, Inc. Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Nordion (Sotera Health) Corporate Information, Location and Competitors
Table 24. Nordion (Sotera Health) Tumor Embolization Major Business
Table 25. Nordion (Sotera Health) Tumor Embolization Total Revenue (USD Million) (2017-2018)
Table 26. Nordion (Sotera Health) SWOT Analysis
Table 27. Nordion (Sotera Health) Tumor Embolization Product and Solutions
Table 28. Nordion (Sotera Health) Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Global Tumor Embolization Revenue (Million USD) by Players (2015-2020)
Table 30. Global Tumor Embolization Revenue Share by Players (2015-2020)
Table 31. Global Tumor Embolization Revenue (Million USD) by Regions (2015-2020)
Table 32. Global Tumor Embolization Revenue Market Share by Regions (2015-2020)
Table 33. North America Tumor Embolization Revenue by Countries (2015-2020)
Table 34. North America Tumor Embolization Revenue Market Share by Countries (2015-2020)
Table 35. Europe Tumor Embolization Revenue (Million USD) by Countries (2015-2020)
Table 36. Asia-Pacific Tumor Embolization Revenue (Million USD) by Countries (2015-2020)
Table 37. South America Tumor Embolization Revenue by Countries (2015-2020)
Table 38. South America Tumor Embolization Revenue Market Share by Countries (2015-2020)
Table 39. Middle East and Africa Tumor Embolization Revenue (Million USD) by Countries (2015-2020)
Table 40. Middle East and Africa Tumor Embolization Revenue Market Share by Countries (2015-2020)
Table 41. Global Tumor Embolization Revenue (Million USD) by Type (2015-2020)
Table 42. Global Tumor Embolization Revenue Share by Type (2015-2020)
Table 43. Global Tumor Embolization Revenue Forecast by Type (2021-2025)
Table 44. Global Tumor Embolization Revenue by Application (2015-2020)
Table 45. Global Tumor Embolization Revenue Share by Application (2015-2020)
Table 46. Global Tumor Embolization Revenue Forecast by Application (2021-2025)
Table 47. Global Tumor Embolization Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tumor Embolization Picture
Figure 2. Global Tumor Embolization Revenue Market Share by Type in 2019
Figure 3. Trans-Arterial Embolization (TAE) Picture
Figure 4. Drug-Eluting Bead Chemoembolization (DEB-TACE) Picture
Figure 5. Radioembolization (RE) Picture
Figure 6. Others Picture
Figure 7. Tumor Embolization Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Specialty Clinics Picture
Figure 11. Others Picture
Figure 12. Global Tumor Embolization Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Tumor Embolization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Tumor Embolization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Tumor Embolization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Tumor Embolization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Tumor Embolization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Tumor Embolization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Tumor Embolization Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Tumor Embolization Revenue Market Share in 2019
Figure 21. Global Top 10 Players Tumor Embolization Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Tumor Embolization Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Tumor Embolization Revenue Market Share by Regions (2015-2020)
Figure 25. Global Tumor Embolization Revenue Market Share by Regions in 2018
Figure 26. North America Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 27. Europe Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 29. South America Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 31. North America Tumor Embolization Revenue Market Share by Countries (2015-2020)
Figure 32. North America Tumor Embolization Revenue Market Share by Countries in 2019
Figure 33. USA Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 34. Canada Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 36. Europe Tumor Embolization Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Tumor Embolization Revenue Market Share by Countries in 2019
Figure 38. Germany Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 39. UK Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 40. France Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 41. Russia Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 42. Italy Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Tumor Embolization Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Tumor Embolization Revenue Market Share by Countries in 2019
Figure 45. China Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 46. Japan Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 47. Korea Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 48. India Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 50. South America Tumor Embolization Revenue Market Share by Countries (2015-2020)
Figure 51. South America Tumor Embolization Revenue Market Share by Countries in 2019
Figure 52. Brazil Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Tumor Embolization Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Tumor Embolization Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 57. UAE Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Tumor Embolization Revenue and Growth Rate (2015-2020)
Figure 60. Global Tumor Embolization Revenue Share by Type (2015-2020)
Figure 61. Global Tumor Embolization Revenue Share by Type in 2019
Figure 62. Global Tumor Embolization Market Share Forecast by Type (2021-2025)
Figure 63. Global Trans-Arterial Embolization (TAE) Revenue Growth Rate (2015-2020)
Figure 64. Global Drug-Eluting Bead Chemoembolization (DEB-TACE) Revenue Growth Rate (2015-2020)
Figure 65. Global Radioembolization (RE) Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Tumor Embolization Revenue Share by Application (2015-2020)
Figure 68. Global Tumor Embolization Revenue Share by Application in 2019
Figure 69. Global Tumor Embolization Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 72. Global Specialty Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Tumor Embolization Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Tumor Embolization Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Tumor Embolization Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Tumor Embolization Revenue Market Forecast (2021-2025)
Figure 78. Europe Tumor Embolization Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Tumor Embolization Revenue Market Forecast (2021-2025)
Figure 80. South America Tumor Embolization Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Tumor Embolization Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
塞栓コイルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Embolization Coils market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Embolization Coils market …- 神経血管塞栓装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Neurovascular Embolization Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neurovascu…
- 血管塞栓デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Vascular Embolization Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vascular Emboli…
- 血管塞栓デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Vascular Embolization Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vascular Emboli…
- 腫瘍切除装置・付属品の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Tumor Ablation Equipment and Accessories market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumo…